MRP
ABBV icon

Measured Risk Portfolios’s AbbVie ABBV Stock Holding History

Measured Risk Portfolios’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Sell
9,287
-1,256
-12% -$270K 2.08% 8
2026
Q1 		$2.29M Buy
10,543
+984
+10% +$218K 2.51% 14
2025
Q4 		$2.18M Sell
9,559
-1,696
-15% -$386K 2.17% 16
2025
Q3 		$2.61M Buy
11,255
+206
+2% +$41.9K 2.43% 6
2025
Q2 		$2.05M Buy
11,049
+294
+3% +$54.6K 1.98% 20
2025
Q1 		$2.25M Sell
10,755
-937
-8% -$182K 2.42% 14
2024
Q4 		$2.08M Buy
+11,692
New +$2.15M 2.17% 17

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Measured Risk Portfolios's ABBV Position: Q2 2026 in Review

Measured Risk Portfolios reduced its AbbVie (ABBV) stake by 12% in Q2 2026, selling an estimated $270K and leaving 9,287 shares worth $2.34M. The position accounts for 2.08% of the portfolio, ranked #8.

Measured Risk Portfolios first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.61M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Measured Risk Portfolios held 9,287 shares of AbbVie worth $2.34M as of Q2 2026.
  • Measured Risk Portfolios sold 1,256 AbbVie shares in Q2 2026, an estimated $270K.
  • AbbVie made up 2.08% of Measured Risk Portfolios's portfolio in Q2 2026, its #8 holding.
  • Measured Risk Portfolios first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Measured Risk Portfolios's AbbVie position peaked at $2.61M in Q3 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Measured Risk Portfolios's 13F filing for Q2 2026, filed 12 Aug 2026.